# Jason Brown

> Jason Brown is a Series B investor at Everest Medicines backing Biotechnology and Pharmaceutical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Everest Medicines](https://shizune.co/investors/profile/everest-medicines)
- Location: Los Angeles, United States
- Total investments: 2
- Last investment: Apr 2012
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/jason-brown/1/214/538

Jason Brown is a Series B investor at Everest Medicines in Los Angeles focused on Biotechnology and Pharmaceutical. Jason Brown is the Chief Business Officer at Everest Medicines. He attended UC San Diego.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Pharmaceutical | 2 | 100% |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tioga Pharmaceuticals | Tioga Pharmaceuticals, Inc. develops therapies for the treatment of gastrointestinal diseases. Its product includes asimadoline, an orally administered small molecule therapeutic for the treatment of irritable bowel syndrome and functional dyspepsia. The company was founded in 2005 and is based in San Diego, California. |  | Series B | Apr 12, 2012 |  |
| NeuroTherapeutics Pharma | NeuroTherapeutics Pharma, Inc., a biopharmaceutical company, develops therapeutics for patients suffering from central nervous system disorders. It focuses on epilepsy, neuropathic, and acute pain disorders of the nervous system. The company was incorporated in 2006 and is based in Chicago, Illinois. |  | Series B | May 20, 2010 |  |

2 of 2 investments shown.

## Co-investors
- [Fidelity Biosciences](https://shizune.co/investors/profile/fidelity-biosciences) — VC Fund, 1 deal together
- [F-Prime](https://shizune.co/investors/profile/f-prime-capital-partners) — VC Fund, 1 deal together
- [Genesys Capital](https://shizune.co/investors/profile/genesys-capital) — VC Fund, 1 deal together
- [GlaxoSmithKline](https://shizune.co/investors/profile/glaxosmithkline) — VC Fund, 1 deal together
- [MPM Capital](https://shizune.co/investors/profile/mpm-capital) — VC Fund, 1 deal together
- [Novo Ventures](https://shizune.co/investors/profile/novo-ventures) — VC Fund, 1 deal together

## About Everest Medicines

VC Fund · New York, United States

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in the Emerging Market including Asia Pacific territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients inthe Emerging Market and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in Asia Pacific territories and with leading global pharmaceutical companies.

3 contacts available at Everest Medicines.

| Name | Title | Profile |
| --- | --- | --- |
| Jason Brown | Chief Business Officer | https://shizune.co/investors/profile/jason-brown-2 |
| Jason Brown | Chief Business Officer | https://shizune.co/investors/profile/jason-brown-d7c4 |
| Steven Hu | Chief Technology Officer | https://shizune.co/investors/profile/steven-hu-deac |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Jason Brown invest in?

Jason Brown invests primarily in Biotechnology, Pharmaceutical and Health Care startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jason Brown last invest?

The most recent investment recorded for Jason Brown closed in Apr 2012. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co